Barclays’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,850
| Closed | -$151K | – | 5276 |
|
|
2020
Q3 | $151K | Sell |
2,850
-571
| -17% | -$35.2K | ﹤0.01% | 4027 |
|
|
2020
Q2 | $210K | Buy |
3,421
+1,386
| +68% | +$80.2K | ﹤0.01% | 4039 |
|
|
2020
Q1 | $115K | Sell |
2,035
-4,100
| -67% | -$234K | ﹤0.01% | 4712 |
|
|
2019
Q4 | $349K | Buy |
6,135
+2,207
| +56% | +$117K | ﹤0.01% | 4592 |
|
|
2019
Q3 | $210K | Sell |
3,928
-27
| -0.7% | -$1.57K | ﹤0.01% | 4929 |
|
|
2019
Q2 | $236K | Buy |
3,955
+1,902
| +93% | +$120K | ﹤0.01% | 4965 |
|
|
2019
Q1 | $128K | Buy |
2,053
+1,878
| +1,073% | +$124K | ﹤0.01% | 5174 |
|
|
2018
Q4 | $11K | Sell |
175
-1,981
| -92% | -$118K | ﹤0.01% | 6151 |
|
|
2018
Q3 | $126K | Buy |
2,156
+1,742
| +421% | +$88.9K | ﹤0.01% | 5359 |
|
|
2018
Q2 | $19K | Sell |
414
-766
| -65% | -$32.9K | ﹤0.01% | 6226 |
|
|
2018
Q1 | $52K | Buy |
1,180
+284
| +32% | +$11.9K | ﹤0.01% | 5883 |
|
|
2017
Q4 | $39K | Buy |
896
+765
| +584% | +$34.4K | ﹤0.01% | 5903 |
|
|
2017
Q3 | $6K | Sell |
131
-1,220
| -90% | -$58.4K | ﹤0.01% | 6383 |
|
|
2017
Q2 | $66K | Sell |
1,351
-5,774
| -81% | -$302K | ﹤0.01% | 5184 |
|
|
2017
Q1 | $390K | Buy |
7,125
+4,725
| +197% | +$250K | ﹤0.01% | 3656 |
|
|
2016
Q4 | $134K | Buy |
2,400
+2,365
| +6,757% | +$114K | ﹤0.01% | 4541 |
|
|
2016
Q3 | $2K | Buy |
+35
| New | +$1.41K | ﹤0.01% | 6308 |
|
|
2016
Q1 | – | Sell |
-761
| Closed | -$32K | – | 6571 |
|
|
2015
Q4 | $32K | Buy |
761
+590
| +345% | +$29.6K | ﹤0.01% | 5018 |
|
|
2015
Q3 | $7K | Sell |
171
-132
| -44% | -$7.12K | ﹤0.01% | 5945 |
|
|
2015
Q2 | $16K | Sell |
303
-814
| -73% | -$34.7K | ﹤0.01% | 5820 |
|
|
2015
Q1 | $45K | Buy |
1,117
+911
| +442% | +$35.7K | ﹤0.01% | 5364 |
|
|
2014
Q4 | $8K | Sell |
206
-582
| -74% | -$22.2K | ﹤0.01% | 6844 |
|
|
2014
Q3 | $27K | Buy |
788
+708
| +885% | +$20.8K | ﹤0.01% | 6305 |
|
|
2014
Q2 | $2K | Buy |
+80
| New | +$2.08K | ﹤0.01% | 7438 |
|
|
2014
Q1 | – | Sell |
-401
| Closed | -$8K | – | 7784 |
|
|
2013
Q4 | $8K | Buy |
401
+400
| +40,000% | +$8.19K | ﹤0.01% | 7072 |
|
|
2013
Q3 | $0 | Sell |
1
-5,288
| -100% | -$93.7K | ﹤0.01% | 7696 |
|
|
2013
Q2 | $82K | Buy |
+5,289
| New | +$85.1K | ﹤0.01% | 5958 |
|
Other funds holding BSTC
Barclays's BSTC Position: Q4 2020 in Review
Barclays sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 2,850 shares — an estimated $151K sold.
Barclays first reported a position in BSTC in Q2 2013 and held it in 27 quarters. The position peaked at $390K in Q1 2017. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Barclays reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Barclays sold 2,850 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $151K.
- Barclays first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 27 quarters.
- Barclays's BioSpecifics Technologies Corp. position peaked at $390K in Q1 2017.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.